Clinical Trial Update: Comparison of Perennial and Preseasonal Subcutaneous Immunotherapy [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing perennial and preseasonal subcutaneous immunotherapy for seasonal allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Subcutaneous immunotherapy (SCIT) allergen extracts (subcutaneous immunotherapy)

Snippet

Sponsor: Medical University of Lodz | Conditions: Seasonal Allergic Rhinitis | Phase 4 | Status: COMPLETED